Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001544227-21-000011

Options or other derivatives

  • Chief Financial Officer acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Minai-Azary Jennifer Lynn Chief Financial Officer 2021-02-26 Grant or award · Stock Option (right to buy) +110,000 110,000 D
Loading xslF345X03/wf-form4_161472352776309.xml…